Shimadzu Corporation

The global gas chromatography market is projected to grow from USD 3.65 billion in 2025 to USD 6.03 billion by 2035, at a compound annual growth rate of 5.15%, according to a new report by SNS Insider. North America held the largest share in 2025 at approximately 43.2%, with the U.S. market alone valued at USD 1.45 billion and expected to reach USD 2.34 billion by 2035. The pharmaceutical and biotechnology companies segment dominated end-use, driven by drug discovery and quality control applications, while the columns segment led accessories and consumables. Asia Pacific is expected to register the fastest growth, supported by expanding pharmaceutical manufacturing and laboratory infrastructure in China, India, and Japan. Recent developments include Shimadzu launching seven new gas chromatography systems in 2025 and Agilent Technologies introducing the 8850 Gas Chromatograph in 2024.

Shimadzu Medical Systems USA has released the FLUOROspeed X1 edition ST, a patient-side conventional RF table system. The system supports a 665-pound static patient weight capacity and a 500-pound all-motion weight capacity, making it suitable for bariatric and routine fluoroscopic and radiographic exams. Standard features include an ambidextrous control handle, fingertip access to APR and image recording functions, and programmable buttons, along with enhancements such as a cross-hair line marker for radiation-free positioning, LED under-deck lighting, a lead apron with a transparent viewing window, and RDSR on all systems. The X1 comes with a 17-by-17-inch dynamic digital X-ray detector in the table bucky and offers a 31.5-inch aperture between tabletop and deck for wheelchair access, fitting into smaller rooms. Shimadzu Medical Systems USA is a subsidiary of Shimadzu Corporation, headquartered in Long Beach, California.